Skip to main content
The BMJ logoLink to The BMJ
letter
. 1994 Mar 5;308(6929):657–658. doi: 10.1136/bmj.308.6929.657c

Fluoroquinolones in upper respiratory tract infections.

M Spiteri
PMCID: PMC2539729  PMID: 8148733

Full text

PDF
657

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachand R. T., Jr Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother. 1991 Feb;27 (Suppl A):91–100. doi: 10.1093/jac/27.suppl_a.91. [DOI] [PubMed] [Google Scholar]
  2. Basran G. S., Joseph J., Abbas A. M., Hughes C., Tillotson G. S. Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin. J Antimicrob Chemother. 1990 Dec;26 (Suppl F):19–24. doi: 10.1093/jac/26.suppl_f.19. [DOI] [PubMed] [Google Scholar]
  3. Körner R. J., Reeves D. S., MacGowan A. P. Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections. BMJ. 1994 Jan 15;308(6922):191–192. doi: 10.1136/bmj.308.6922.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Powell M., McVey D., Kassim M. H., Chen H. Y., Williams J. D. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. J Antimicrob Chemother. 1991 Aug;28(2):249–259. doi: 10.1093/jac/28.2.249. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES